Coexpression cluster:C2622

Full id: C2622_Osteoblast_Chondrocyte_meningioma_Fibroblast_mesenchymal_Smooth_tenocyte

Phase1 CAGE Peaks

Hg19::chr20:57090346..57090361,-	p6@APCDD1L
Hg19::chr20:57090369..57090380,-	p7@APCDD1L
Hg19::chr20:57090389..57090412,-	p3@APCDD1L
Hg19::chr20:57090438..57090462,-	p1@APCDD1L

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n
muscle precursor cell	3.32e-18	58
myoblast	3.32e-18	58
multi-potent skeletal muscle stem cell	3.32e-18	58
vascular associated smooth muscle cell	2.21e-17	32
fibroblast	5.82e-17	76
contractile cell	1.08e-16	59
muscle cell	2.95e-16	55
non-terminally differentiated cell	8.62e-16	106
smooth muscle cell	1.19e-15	43
smooth muscle myoblast	1.19e-15	43
somatic stem cell	1.39e-15	433
stem cell	1.42e-15	441
multi fate stem cell	2.43e-15	427
electrically responsive cell	6.59e-14	61
electrically active cell	6.59e-14	61
somatic cell	3.12e-12	588
skin fibroblast	5.85e-11	23
aortic smooth muscle cell	2.21e-08	10
animal cell	2.96e-08	679
eukaryotic cell	2.96e-08	679

Uber Anatomy

Ontology term	p-value	n
multilaminar epithelium	9.03e-23	83
somite	2.99e-22	71
presomitic mesoderm	2.99e-22	71
presumptive segmental plate	2.99e-22	71
dermomyotome	2.99e-22	71
trunk paraxial mesoderm	2.99e-22	71
dense mesenchyme tissue	3.35e-22	73
paraxial mesoderm	1.17e-21	72
presumptive paraxial mesoderm	1.17e-21	72
epithelial vesicle	4.05e-21	78
muscle tissue	1.92e-18	64
musculature	1.92e-18	64
musculature of body	1.92e-18	64
skeletal muscle tissue	5.29e-18	62
striated muscle tissue	5.29e-18	62
myotome	5.29e-18	62
mesenchyme	6.63e-14	160
entire embryonic mesenchyme	6.63e-14	160
systemic artery	2.13e-13	33
systemic arterial system	2.13e-13	33
artery	2.46e-13	42
arterial blood vessel	2.46e-13	42
arterial system	2.46e-13	42
trunk mesenchyme	2.06e-12	122
mesoderm	4.27e-12	315
mesoderm-derived structure	4.27e-12	315
presumptive mesoderm	4.27e-12	315
surface structure	2.28e-09	99
musculoskeletal system	3.30e-09	167
smooth muscle tissue	5.42e-09	15
integument	9.54e-09	46
integumental system	9.54e-09	46
blood vessel smooth muscle	2.21e-08	10
arterial system smooth muscle	2.21e-08	10
artery smooth muscle tissue	2.21e-08	10
aorta smooth muscle tissue	2.21e-08	10
skin of body	5.52e-08	41
epithelial tube open at both ends	1.14e-07	59
blood vessel	1.14e-07	59
blood vasculature	1.14e-07	59
vascular cord	1.14e-07	59
unilaminar epithelium	2.51e-07	148
splanchnic layer of lateral plate mesoderm	3.08e-07	83
connective tissue	7.10e-07	371
trunk	9.01e-07	199

Disease

Ontology term	p-value	n
ovarian cancer	5.41e-10	14
female reproductive organ cancer	5.74e-07	27

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF	#promoters	Enrichment	p-value	q-value
MYC#4609	4	5.2222818716094	0.00134430939527274	0.00888315905934131
USF1#7391	4	6.36149927720796	0.000610501139914083	0.00508372895483072

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.